Dr. Sharrell Cooper, M.D
Family Medicine (Family Medicine Physician)
1 Memorial Medical Pkwy Ste 201
Palm Coast, FL 32164
Who else practices at this address →
Flagler County is a federal primary care shortage area. About shortage areas
- Medicare participating
At a glance
- Medical school
- Eastern Virginia Medical School (2012)
- Years since graduation
- 14
- In the NPI registry since
- 2013
- Medicare patients seen, 2024
- 14
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2012Medical school: Eastern Virginia Medical School
- 2013Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Family Medicine Physician primary
FL license ME 117633
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Adventhealth PAlm Coast Palm Coast, FL
Medical groups
- Adventhealth Primary Care Network Inc (450 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 14
- Services billed
- 23
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 203 | 187 |
| Annual depression screening, 5 to 15 minutes | 63 | 63 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 61 | 61 |
| Annual alcohol misuse screening, 5 to 15 minutes | 57 | 57 |
| Established patient office or other outpatient visit, 20-29 minutes | 47 | 46 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Industry-funded research
Named as a principal investigator on 9 industry-funded studies in 2025, from 3 companies. The companies reported $15,299,669 in research payments for these studies, mostly to the institutions running them.
- A Phase 1, Double Blind, Multiple Dose, Placebo-Controlled, Parallel Group Study to Evaluate the Impact of AMG 133 on Gastric Emptying in Participants Living with Overweight or Obesity
Amgen Inc. - A Phase 1, Randomized, Double-blind, Placebo- and Positive-controlled, Parallel Group Study With Nested Crossover Comparison to Assess the Effect of Maridebart Cafraglutide on QT/QTc Intervals in Participants Living W…
Amgen Inc. - A Phase 1, Open-label, Randomized, Parallel-group Study to Assess the Relative Bioavailability of Maridebart Cafraglutide (AMG 133) as Two Subcutaneous Presentations in Participants Living With Overweight or Obesity
Amgen Inc. - A Study to Assess the Tolerability and Safety of Subcutaneously (SC) Administered Immunoglobulin G (IgG) With Varying Injection Conditions
Genentech, Inc. - GDC-6036 (Divarasib)
Genentech, Inc. - A Study of LY3549492 in Healthy Participants and Participants With Overweight or Obesity
Eli Lilly and Company · Completed · NCT07232732 - Astegolimab
Genentech, Inc. - A Phase 1, Open label, Randomized, Single Dose Crossover Study to Assess the Relative Bioavailability of Olpasiran (AMG 890) Autoinjector and Prefilled Syringe in Healthy Participants
Amgen Inc. - A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis
Eli Lilly and Company · Recruiting · NCT07258849
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.